In-house Pipeline
: IIT
: SIT
Pipeline
Indication
| Pipeline | Indication | in silico | in vitro | in vivo | IND | clinical trials |
|---|---|---|---|---|---|---|
| OC101 | Liver Cirrhosis |
OC101
Liver Cirrhosis
|
||||
| OC101+OC111 | NASH |
OC101+OC111
NASH
|
||||
| OC201+OC202e | Inhibition of Cancer Metastasis |
OC201+OC202e
Inhibition of Cancer Metastasis
|
||||
| OC211 | Pan-KRAS Inhibitor |
OC211
Pan-KRAS Inhibitor
|
||||
| OC221 | Immuno-Oncology Combi |
OC221
Immuno-Oncology Combi
|
||||
| OC514 | Multiple Muscular Diseases |
OC514
Multiple Muscular Diseases
|
||||
| (Sarcopenia, ALS, DMD) |
(Sarcopenia, ALS, DMD)
|
|||||
| OC701 | Atopic Dermatitis |
OC701
Atopic Dermatitis
|
||||
